Elevated plasma cholesterol causally improves sepsis outcome by promoting hepatic metabolic reprogramming
Qian Wang, Jianyao Xue, Ling Guo, Dan Hao, Misa Ito, Rianna Reese, Bin Huang, Congqing Wu, Xiang‐An Li
This study shows elevated plasma cholesterol improves sepsis survival by promoting hepatic metabolic reprogramming, as demonstrated in both human patients and mouse models.
Frontiers in Immunology · May 11, 2026Peer-reviewedPhysiology